Osteonecrosis of the Jaw: Effect of Bisphosphonate Type, Local Concentration, and Acidic Milieu on the Pathomechanism
- 1 November 2010
- journal article
- research article
- Published by Elsevier BV in Journal of Oral and Maxillofacial Surgery
- Vol. 68 (11), 2837-2845
- https://doi.org/10.1016/j.joms.2010.07.017
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws—2009 UpdateJournal of Oral and Maxillofacial Surgery, 2009
- The Role of Inferior Alveolar Nerve Involvement in Bisphosphonate-Related Osteonecrosis of the JawJournal of Oral and Maxillofacial Surgery, 2009
- Bisphosphonate-induced osteonecrosis of the jaws: Prospective study of 80 patients with multiple myeloma and other malignanciesOral Oncology, 2008
- Prevalence and Risk Factors of Bisphosphonate-Associated Osteonecrosis of the Jaw in Prostate Cancer Patients with Advanced Disease Treated with ZoledronateEuropean Urology, 2008
- “Bis-phossy jaws” – High and low risk factors for bisphosphonate-induced osteonecrosis of the jawJournal of Cranio-Maxillofacial Surgery, 2008
- Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral ResearchJournal of Bone and Mineral Research, 2007
- Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk FactorsJournal of Clinical Oncology, 2005
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- Osteonecrosis of the jaws associated with cancer chemotherapyJournal of Oral and Maxillofacial Surgery, 2003
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003